Home  /  Resource Library  /  Checkpoint Inhibition Therapy in Transplant-Ineligible Relapsed or Refractory Classic Hodgkin Lymphoma

Checkpoint Inhibition Therapy in Transplant-Ineligible Relapsed or Refractory Classic Hodgkin Lymphoma

Article discusses the use of PD-1 checkpoint inhibitors for treatmentof relapsed Hodgkin lymphoma.